Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
67.05
-0.18 (-0.27%)
Apr 1, 2026, 4:00 PM EDT - Market closed

Inhibrx Biosciences Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Inhibrx Biosciences in the last 12 months.

Price Target: n/a
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

The average analyst rating for Inhibrx Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingOct '25Nov '25Dec '25Jan '26Feb '26Mar '26
Strong Buy000000
Buy000000
Hold222222
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JMP Securities
JMP Securities
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 22, 2025
JMP Securities
JMP Securities
Hold
Reiterates
n/a
HoldReiteratesn/an/aMay 15, 2025
Citizens Capital Markets
Citizens Capital Markets
Hold
Reiterates
n/a
HoldReiteratesn/an/aMar 18, 2025
JMP Securities
JMP Securities
Hold
Reiterates
n/a
HoldReiteratesn/an/aJan 22, 2025
JMP Securities
JMP Securities
Hold
Initiates
n/a
HoldInitiatesn/an/aJul 23, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 1.30M
Revenue Next Year
99.60M
EPS This Year
-4.85
from -9.04
EPS Next Year
-2.81
from -4.85
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2028
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2028
Revenue
7.23M1.32M1.80M200.00K1.30M-99.60M
Revenue Growth
-43.89%-81.81%36.88%-88.89%550.00%--
EPS
-2.15-2.88-20.48112.62-9.04-4.85-2.81
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2026202820292030
Highn/a102.5M
Avgn/a99.6M
Lown/a95.7M

Revenue Growth

Revenue Growth2026202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-5.00-2.89
Avg-4.85-2.81
Low-4.66-2.70

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.